Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Global Value Dossier

- PMLiVE

Sir Christopher Gent ‘stepping down’ as GSK chair

He will leave the pharma firm in the next two or three years, according to a UK press report

Market access opportunities in China

Pope Woodhead highlights the key steps to accessing the high-value therapeutics market in China

- PMLiVE

Guide to gamification

How to execute digital: Using gaming as part of a pharma marketing campaign

- PMLiVE

Incite strengthens its healthcare team

Emily Peasgood joins agency as principal

- PMLiVE

Atlantis Healthcare Group bring in new UK MD

Charles MacKinnon will take over from Kate Reid

- PMLiVE

Dare to be Different

As R&D struggles to deliver and generic competition soars, the opportunity to differentiate your brand has never been more crucial. But how you do it? Our author, an expert on...

- PMLiVE

Boehringer-Lilly win expanded European licence for Trajenta

Type 2 diabetes drug approved as add-on to insulin in adults

- PMLiVE

GSK, Pfizer and Shionogi rewrite HIV joint venture terms

Comes ahead of first regulatory submissions for lead drug candidate dolutegravir

- PMLiVE

FDA approves Teva’s leukaemia drug Synribo

Accelerated approval means early competition for Pfizer’s Bosulif

- PMLiVE

Merck misses revenue targets as Singulair slumps

Asthma drug hit hard by generic competition in the US

- PMLiVE

Who Do We Think We Are?

After all these years, are we still patronising our audience at our peril?

Novartis building

France, Germany and Spain join list of countries banning Novartis vaccines

Flu vaccines Agrippal and Fluad withdrawn after some batches found to be contaminated

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links